CPT point of care analyzers - CG8+
Ended Awarded Last action
- Contract number
- N6264520F0147
- Awardee
-
Abbott Laboratories Inc. UEI L3AXXYLB3V56 Part of Abbott Laboratories
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,196,690
Award facts
- Contract value 96% obligated
- $1,251,748.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Norfolk, VA 23523, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $11,149 | |
| Funding Only Action | -$127,420 | |
| Exercise an Option | $262,592 | |
| Exercise an Option | $262,592 | |
| Exercise an Option | $262,592 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $262,592 | |
| Other Administrative Action | $0 | |
| Original award | $262,592 |
About this award
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1.25M by the Defense Health Agency on September 2, 2020, for CPT Point of Care Analyzers—specifically CG8+ blood analyzers. The contract is firm fixed price with no small business set-aside designation, indicating full and open competition. Performance is based in Norfolk, Virginia, with an ultimate completion date of August 31, 2025. This delivery order is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule, which streamlines federal procurement of diagnostic laboratory equipment and enables efficient ordering of medical technologies across defense healthcare systems.
The Defense Health Agency selected Abbott Laboratories, a global healthcare company specializing in medical devices and diagnostic technologies, to supply point-of-care blood analysis equipment to support military medical operations. Abbott's Point of Care division has established itself as a key provider of diagnostic analyzers and testing platforms to federal healthcare agencies, particularly the Department of Veterans Affairs and Department of Defense. The delivery order mechanism allows the Defense Health Agency to draw down quantities of the specified analyzer equipment as operational needs require, providing flexible procurement of critical laboratory diagnostics for military medical facilities.
Quick answers
Who was awarded contract N6264520F0147?
N6264520F0147 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on September 2, 2020.
How much is contract N6264520F0147 worth?
The government has obligated $1,196,690 on N6264520F0147. Its current value, with exercised options, is $1,251,748.
Is contract N6264520F0147 an order under another contract?
Yes. N6264520F0147 is a delivery order under V797P7322A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract N6264520F0147 competed?
The extent of competition for N6264520F0147 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award